Gemphire sparkles on third trial win for lead drug gemcabene

Gemphire sparkles on third trial win for lead drug gemcabene

Source: 
Fierce Biotech
snippet: 

Shares in Gemphire Therapeutics more than doubled after its lead drug gemcabene aced a midstage trial in patients with high triglycerides—setting up a phase 3 program.